Download PDF
Diabetes aktuell 2016; 14(06): 282-287
DOI: 10.1055/s-0042-117668
Schwerpunkt
© Georg Thieme Verlag Stuttgart · New York

Die Grenzen der Adipositastherapie

Warum die Betroffenen oft doch nicht abnehmenLimits of obesity therapy - Why many patients don‘t loose weight after all
Markus Reiser
1   Klinik für Innere Medizin II, Klinikum Vest GmbH, Paracelsus-Klinik Marl
› Author Affiliations
Further Information

Publication History

Publication Date:
26 October 2016 (online)

Also available at
    Permissions and Reprints

Die zunehmende Adipositasprävalenz ist ein weltweites Gesundheitsproblem. Konservative, medikamentöse und endoskopische Therapiestrategien sind dabei wenig erfolgreich und die bariatrische Chirurgie ist nur für einen kleinen Patientenkreis nutzbar.

The increasing prevalence of obesity is a worldwide health problem. Conservative therapies, drug therapies, and endoscopic therapies are providing no real benefit, and bariatric surgery is only available for a small amount of patients.

Key words

obesity - diet - medical therapy - endoscopic therapy - bariatric surgery
 

  • Literatur

  • 1 WHO. Global Comparable Estimates, Risk Factors etc.. https://apps.who.int/infobase/ (Stand: 23.5.16)
    Google Scholar
  • 2 Branca F, Nikogosian H, Lobstein T ed. The challenge of obesity in the WHO European Region and the strategies for response: summary. www.euro.who.int/en/publications/abstracts/challenge-of-obesity-in-the-who-european-region-and-the-strategies-for-response-the.-summary (Stand: 23.5.16)
    Google Scholar
  • 3 Flegal KM et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309: 71-82
    CrossrefGoogle Scholar
  • 4 Calle EE et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638
    CrossrefGoogle Scholar
  • 5 Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metabol 2004; 89: 2548-2556
    CrossrefGoogle Scholar
  • 6 Apovian CM et al. Pharmacological management of obesity: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metabol 2015; 100: 342-362
    CrossrefGoogle Scholar
  • 7 Bueter M, le Roux CW. Gastrointestinal hormones, energy balance and bariatric surgery. International J Obes 2011; 35: 35-S39
    Google Scholar
  • 8 Suzuki K et al. The gut hormones in appetite regulation. J Obes 2011; 2011: 1-10
    Google Scholar
  • 9 Farooqi IS et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348: 1085-1095
    CrossrefGoogle Scholar
  • 10 Wabitsch M et al. Biologically inactive leptin and early-onset extreme obesity. N Engl J Med 2015; 372: 48-54
    CrossrefGoogle Scholar
  • 11 Speliotes EK et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010; 42: 937-948
    CrossrefGoogle Scholar
  • 12 Sacks FM et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009; 360: 859-873
    CrossrefPubMedGoogle Scholar
  • 13 Sumithran P et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 2011; 365: 1597-1604
    CrossrefGoogle Scholar
  • 14 Fildes A et al. Probability of an Obese Person Attaining Normal Body Weight: Cohort Study Using Electronic Health Records. Am J Public Health 2015; 105: e54-e59
    CrossrefGoogle Scholar
  • 15 Saltiel AR. New therapeutic approaches for the treatment of obesity. Sci Transl Med 2016; 8: 1-11
    Google Scholar
  • 16 Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med 2015; 373: 11-22
    Google Scholar
  • 17 Rodgers RJ et al. Anti-obesity drugs: past, present and future. Dis Model Mech 2012; 5: 621-626
    CrossrefGoogle Scholar
  • 18 Chen Z et al. Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity. J Clin Invest 2014; 124: 3391-3406
    CrossrefGoogle Scholar
  • 19 Fernandes M et al. Intragastric balloon for obesity. Cochrane Database Syst Rev 2007; CD004931
    Google Scholar
  • 20 Patel SRH et al. The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes. Surg Obes Relat Dis 2013; 9: 482-484
    CrossrefGoogle Scholar
  • 21 Sullivan S et al. Aspiration therapy leads to weight loss in obese subjects: a pilot study. Gastroenterol 2013; 145: 1245-1252
    CrossrefGoogle Scholar
  • 22 Bang CS et al. Effect of intragastric injection of botulinum toxin A for the treatment of obesity: a meta-analysis and meta-regression. Gastrointest Endosc 2015; 81: 1141-1149
    CrossrefGoogle Scholar
  • 23 Deutsche Adipositas Gesellschaft. Interdisziplinäre Leitlinie der Qualität S3 zur „Prävention und Therapie der Adipositas“. AWMF-Register Nr. 050/001 2014. www.adipositas-gesellschaft.de/fileadmin/PDF/Leitlinien/S3_Adipositas_Praevention_Therapie_2014.pdf (Stand: 23.5.16)
    Google Scholar
  • 24 Sandoval D. Bariatric surgeries: beyond restriction and malabsorption. Int J Obes 2011; 35: 45-49
    Google Scholar
  • 25 Golomb I et al. Long-term metabolic effects of laparoscopic seeve gastrectomy. JAMA Surg 2015; 150: 1051-1057
    CrossrefPubMedGoogle Scholar
  • 26 Gloy VL et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 2013; 347: f5934
    CrossrefGoogle Scholar
  • 27 Karmali S et al. Weight recidivism post-bariatric surgery: a systematic review. Obes Surg 2013; 23: 1922-1933
    CrossrefPubMedGoogle Scholar
  • 28 Bocca G et al. Results of a multidisciplinary treatment program in 3-year-old to 5-year-old overweight or obese children: a randomized controlled clinical trial. Arch Pediatr Adolesc Med 2012; 166: 1109-1115
    CrossrefGoogle Scholar
  • 29 Danielsson P et al. Response of severely obese children and adolescents to behavioral treatment. Arch Pediatr Adolesc Med 2012; 166: 1103-1108
    CrossrefGoogle Scholar